Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS
No-Receipt date
2013-00579 - 25/02/2013
No-Filing date
20130400404 - 25/02/2013
No-Granting date
3080196 - 28/02/2013
No-EPO application date
08719896.6 - 04/04/2008
No-EPO granting date
2079456 - 05/12/2012
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
2/2013 - 27/03/2013
Expiration date
05/04/2028
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US907490 P04/04/2007/US
US6498 P16/01/2008/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 9/50
A61K 31/436
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1222184
SUBLIMITY THERAPEUTICS LIMITED
INVENT CENTRE DUBLIN CITY UNIVERSITY
DUBLIN 9
IRELAND
Inventors
Code
Firstname
Surname
1087100
COULTER, IVAN
Representatives
Code
Firstname
Surname
Address
Town
Zip
3098
ANNA
GIAKOUMI
ALKAMENOUS 12-14
ATHINA (ATTIKIS)
10439
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8349
ANNA
GIAKOUMI
ALKAMENOUS 12-14
ATHINA (ATTIKIS)
10439
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
02/07/2020
Αλλαγή Επωνυμίας Δικαιούχου (7e801)
Α.Π.6160, ΑΡ.ΥΠ.3042646/6-20, ΔΝΥ800, ΚΩΔ.ΠΛΗΡ.3098
456205 Sigmoid Pharma Limited Invent Centre Dublin City University ΙΡΛΑΝΔΙΑ Dublin 9
1222184 Sublimity Therapeutics Limited Invent Centre Dublin City University ΙΡΛΑΝΔΙΑ Dublin 9
Title Instruments
Date
Operation
Descreption
11/4/2024 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 10/2024 Αρ. Πρωτ. ΓΔ 3111/04.11.2024
Payments history
16 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).